Sentiment-Signal
22,2
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Kritische 8-K Meldungen
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 30.04.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensato |
| 24.01.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensat |
| 10.01.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensato |
| 23.05.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensat |
| 15.05.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | rence in such a filing. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of C |
| 06.02.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensato |
| 13.10.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensato |
| 31.08.2023 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | ct. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Of |
Stammdaten
Atai Beckley NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Amstelveen, Netherlands.
Unternehmen & Branche
| Name | Atai Beckley N.V. |
|---|---|
| Ticker | ATAI |
| CIK | 0001840904 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Pharmaceuticals |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | 45822R101 |
|---|---|
| ISIN | US45822R1014 |
| Typ | Common Stock |
| Marktkapitalisierung | 770,5 Mio. USD |
| Beta | 1,57 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-09-30 | 10-Q | 749,000 | -61,074,000 | -0.28 | 239,820,000 | 159,751,000 |
| 2025-06-30 | 10-Q | 719,000 | -27,729,000 | -0.14 | 189,204,000 | 143,738,000 |
| 2025-03-31 | 10-Q | 1,555,000 | -26,431,000 | -0.15 | 195,783,000 | 152,053,000 |
| 2024-12-31 | 10-K | 308,000 | -149,269,000 | -0.93 | 159,387,000 | 116,297,000 |
| 2024-09-30 | 10-Q | 40,000 | -26,286,000 | -0.16 | 197,519,000 | 145,720,000 |
| 2024-06-30 | 10-Q | 273,000 | -57,312,000 | -0.36 | 215,778,000 | 167,890,000 |
| 2024-03-31 | 10-Q | 0 | -26,713,000 | -0.17 | 269,121,000 | 222,544,000 |
| 2023-12-31 | 10-K | 314,000 | -40,224,000 | -0.25 | 293,478,000 | 242,962,000 |
| 2023-09-30 | 10-Q | 87,000 | 44,244,000 | 0.25 | 308,220,000 | 266,276,000 |
| 2023-06-30 | 10-Q | 172,000 | -33,042,000 | -0.21 | 253,595,000 | 212,550,000 |
| 2023-03-31 | 10-Q | 37,000 | -33,135,000 | -0.21 | 280,717,000 | 236,825,000 |
| 2022-12-31 | 10-K | 233,000 | -152,385,000 | -0.98 | 305,441,000 | 260,740,000 |
| 2022-09-30 | 10-Q | 24,000 | -33,887,000 | -0.22 | 342,597,000 | 289,399,000 |
| 2022-06-30 | 10-Q | 170,000 | -36,618,000 | -0.24 | 348,936,000 | 311,675,000 |
| 2022-03-31 | 10-Q | 0 | -36,869,000 | -0.24 | 383,732,000 | 346,006,000 |
| 2021-12-31 | 10-K | 20,376,000 | -167,808,000 | -1.21 | 414,166,000 | 376,908,000 |
| 2021-09-30 | 10-Q | 266,000 | -31,158,000 | -0.21 | 484,109,000 | 453,186,000 |
| 2021-06-30 | 10-Q | 0 | -48,461,000 | -0.37 | ||
| 2021-03-31 | 10-Q | 19,880,000 | 688,000 | 0.01 | ||
| 2020-12-31 | 10-K | 0 | -169,843,000 | 111,548,000 | 90,822,000 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2025-08-14 | Apeiron Investment Group Ltd. | 10% Owner | Open Market Purchase | 8,675,799 | 2.19 | 18,999,999.81 | +100,0% |
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.